Categories: Health

Iridex to Participate in Fireside Chat with Stifel Equity

Published by
Globe News Wire

MOUNTAIN VIEW, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) — Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in a fireside chat with its covering equity research analyst from Stifel.

Management is scheduled to discuss the business on Thursday, December 8, 2022 at 9:00 a.m. PT / 12:00 p.m. ET. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at:

About Iridex
Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit

Investor Relations Contact:
Philip Taylor
(415) 937-5406

Globe News Wire
Published by
Globe News Wire

Recent Posts

Bubblr Re-Appoints Founder Stephen Morris to Its Board of

NEW YORK, NY, Jan. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Bubblr, Inc., (OTC… Read More

19 mins ago

BioSenic appoints Yves Sagot as Independent Director

REGULATED INFORMATION Mont-Saint-Guibert, Belgium, January 27, 2023, 7am CET – BioSenic (Euronext Brussels and Paris:… Read More

20 mins ago

CLOVER HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating Clover Health Investments Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is… Read More

22 mins ago

Reliq Health Technologies, Inc. Announces 30 New Skilled

HAMILTON, Ontario, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF… Read More

1 hour ago

Press Release: Dupixent® (dupilumab) recommended for

Dupixent® (dupilumab) recommended for expanded EU approval by the CHMP to treat children as young… Read More

1 hour ago

Toyota Tsusho, IIJ, NEC, and NTT Com Sign Contract with Uzbektelecom for Telecommunications Infrastructure Development Project

- Contributing to DX efforts by advancing Uzbekistan's information and telecommunications infrastructure - TOKYO--(BUSINESS WIRE)--Toyota… Read More

1 hour ago